BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 28365573)

  • 1. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
    Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
    J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
    Kim HA; An JM; Nam JY; Jeon JY; Suh CH
    J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
    Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
    J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
    Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
    Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
    Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
    Jung JY; Suh CH; Sohn S; Nam JY; Kim HA
    Clin Rheumatol; 2016 Aug; 35(8):1937-1942. PubMed ID: 27225247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease.
    Han JH; Ahn MH; Jung JY; Suh CH; Kwon JE; Yim H; Kim HA
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):67-73. PubMed ID: 31287410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
    Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
    Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
    Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
    J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
    Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
    Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
    Kim HA; Choi B; Suh CH; Han MH; Jung JY; Sayeed HM; Kim YW; Sohn S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of free interleukin-18 in adult-onset Still's disease.
    Girard C; Rech J; Brown M; Allali D; Roux-Lombard P; Spertini F; Schiffrin EJ; Schett G; Manger B; Bas S; Del Val G; Gabay C
    Rheumatology (Oxford); 2016 Dec; 55(12):2237-2247. PubMed ID: 27616144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
    Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
    Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Interleukin-18 Provides a Clue to the Diagnosis of Adult-Onset Still's Disease: Findings from 6 Japanese Patients with Adult-Onset Still's Disease.
    Ogita A; Ansai SI; Saeki H
    J Nippon Med Sch; 2022 Mar; 89(1):114-118. PubMed ID: 34526450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokine profiles in patients with adult onset Still's disease.
    Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
    J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
    Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
    Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.